XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Condensed Financial Information Disclosure [Abstract]  
Schedule of financial statements
   As
Previously
Reported
   Adjustments   As
Restated
 
Balance Sheet as of December 31, 2020               
Ordinary shares subject to possible redemption  $2,149,607   $13,215,384   $15,364,991 
Ordinary shares  $2,410,382   $(2,410,382)  $
-
 
Retained earnings (accumulated deficit)  $2,589,624   $(10,805,002)  $(8,215,378)
Total shareholders’ equity (deficit)  $5,000,006   $(13,215,384)  $(8,215,378)

 

   As
Previously
Reported
   Adjustments   As
Restated
 
Balance Sheet as of March 31, 2021               
Ordinary shares subject to possible redemption  $1,979,445   $13,597,949   $15,577,394 
Ordinary shares  $2,580,544   $(2,580,544)  $
-
 
Retained earnings (accumulated deficit)  $2,419,464   $(11,017,405)  $(8,597,941)
Total shareholders’ equity (deficit)  $5,000,008   $(13,597,949)  $(8,597,941)

 

Schedule of statement of operations
   As
Previously
Reported
   Adjustments   As
Restated
 
Statement of Operations for the Three Months Ended March 31, 2020               
Net income  $402,558   $
-
   $402,558 
Less: income attributable to ordinary shares subject to possible redemption  $(479,809)  $479,809   $
-
 
Adjusted net loss  $(77,251)  $77,251   $
-
 
Basic and diluted weighted average redeemable ordinary shares outstanding   
-
    11,487,992    11,487,992 
Basic and diluted net loss per redeemable ordinary share  $
-
   $(0.09)  $(0.09)
Basic and diluted weighted average non-redeemable ordinary shares outstanding   4,263,670    (1,061,912)   3,201,758 
Basic and diluted net loss per non-redeemable ordinary share  $(0.02)  $(0.07)  $(0.09)

 

   As
Previously
Reported
   Adjustments   As
Restated
 
Statement of Operations for the Three Months Ended March 31, 2021               
Net loss  $(170,160)  $
-
   $(170,160)
Less: income attributable to ordinary shares subject to possible redemption  $(48)  $48   $
-
 
Adjusted net loss  $(170,208)  $170,208   $
-
 
Basic and diluted weighted average redeemable ordinary shares outstanding   
-
    1,413,480    1,413,480 
Basic and diluted net loss per redeemable ordinary share  $
-
   $(0.08)  $(0.08)
Basic and diluted weighted average non-redeemable ordinary shares outstanding   4,417,482    (1,215,724)   3,201,758 
Basic and diluted net loss per non-redeemable ordinary share  $(0.04)  $(0.04)  $(0.08)

 

Schedule of statement of cash flows
   As
Previously
Reported
   Adjustments   As
Restated
 
Statement of Cash Flows for the Three Months Ended March 31, 2020               
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $402,566   $(402,566)  $
-
 
Accretion of carrying value to redemption value  $
-
   $1,683,168   $1,683,168 

 

   As
Previously
Reported
   Adjustments   As
Restated
 
Statement of Cash Flows for the Three Months Ended March 31, 2021               
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $170,162   $(170,162)  $
-
 
Accretion of carrying value to redemption value  $
-
   $212,403   $212,403